Across TCGA pan-cancer cohorts, TAF9BP2 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated TAF9BP2 data layer.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher TAF9BP2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TAF9BP2 expression acts as an unfavorable survival marker, although some lineages such as MESO and OV show a favorable association.
COAD, KIRC, and MESO are the cancer types where TAF9BP2 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.